Hi Tassie,
I think thats a combo of Optivo and Yervoy.
Optivo came in with some good results at ESMO 14% adverse effect.
Looking at that trial release at ESMO for Cavatak Iam now not sure it had any new Data which might explain the lack of announcement.
Aloha.
Add to My Watchlist
What is My Watchlist?